Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 41

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 41
---
 aligns executive and stockholder interests because:

| The use of multi-yearvesting for equity awardsencourages executiveretention and emphasizesthe attainment of long-termperformance goals. |     | Paying a significant portion ofexecutive compensation withlong-term incentives motivatesand incentivizes the executiveofficers to meet the long-termperformance goals set by theCompensation and TalentManagement Committee. |     | The executive officers will holdsignificant amounts of equityin the Company as requiredby the Company’s StockOwnership Guidelines andwill be motivated to increasestockholder value over thelong-term. |

In May 2024, following discussions with CAP and review of the benchmarking data for our executive officers, the Compensation and Talent Management Committee increased target award values for each executive for FY2025 to move each closer to the median of the peer group. Target award values increased, as provided in the table below.

| Name         | FY2025 TargetedAward Value |            | % Increasefrom FY2024 |
| Mr. Lombardi |                            | $4,000,000 |                   8.1 |
| Ms. Sacco    |                            | $1,575,000 |               52.9(*) |
| Mr. Mekhail  |                            |   $528,000 |                   2.5 |
| Mr. P’Pool   |                            |   $546,000 |                   1.1 |
| Mr. Zerillo  |                            |   $370,000 |                   2.8 |

For our CEO, the Compensation and Talent Management Committee allocated seventy-five percent (75%) of his targeted equity award value to performance stock units and the remaining twenty-five percent (25%) to restricted stock units. For our other named executive officers, the Compensation and Talent Management Committee allocated sixty percent (60%) of the targeted equity award value to performance stock units, and forty percent (40%) to restricted stock units. In each case, the actual number of stock units granted was determined by dividing the allocated dollar value by the closing price of the Company’s common stock on the grant date. The 2025 equity grants to our named executive officers are set forth in the Grants of Plan-Based Awards table later in this Proxy Statement. * Ms. Sacco’s increase reflects an increase due to her promotion to Chief Operating Officer, in addition to her role as Chief Financial Officer, in January 2025.

| Prestige Consumer Healthcare Inc. | 2025 Proxy Statement |     |